Evidence map›Paper›PMID 40576420›Full record

ArticleJournal of cell science2025

The scaffold protein CasL restrains membrane blebbing and promotes T cell migration.

Liz A Kurtz, Hope E Shearer, Rosanne Trevail, Menelaos Symeonides, Mobin Karimi, Nathan H Roy

Abstract read
In one paragraph

Article in Journal of cell science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liz A KurtzDepartment of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.
Hope E ShearerDepartment of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.
Rosanne TrevailDepartment of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.
Menelaos SymeonidesDepartment of Microbiology & Molecular Genetics, University of Vermont, Burlington, VT 05403, USA.
Mobin KarimiDepartment of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.
Nathan H RoyDepartment of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.ORCID 0000-0003-1229-2808

Funding

Using Dengue Controlled Human Infection Model to Identify Adaptive Immune Correlates of ProtectionP20GM125498 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Kristen Pierce · 2018 to 2026
$24.9M
Defining CasL as an Orchestrator of T cell MigrationR01AI185016 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI Nathan H. Roy · 2024 to 2026
$1.2M
Carol M. Baldwin Breast Cancer Research FundCarol M. Baldwin Breast Cancer Research Fund 99040Division of Intramural Research, National Institute of Allergy and Infectious Diseases R01AI185016NIAID NIH HHS R01 AI185016NIGMS NIH HHS P20 GM125498NIH HHS AI185016NIH HHS P20 GM125498Richard and Jean Clark Pediatric Research FundUniversity of VermontUpstate Cancer CenterUpstate FoundationUpstate University Cancer Center
6 · The paper itself

Abstract

T cell migration into inflamed tissue is a key control point in the inflammatory response and relies on integrin interactions with their endothelial ligands. Here, we identify the signaling scaffold CasL (also known as Hef1 and NEDD9) as a central regulator of integrin-dependent migration in primary T cells. We found that CasL is specifically needed for efficient migration on ICAM-1-, but not VCAM-1-coated surfaces. Although wild-type T cells migrating on ICAM-1 formed an actin-rich cell front and move smoothly, T cells lacking CasL instead formed numerous, aberrant membrane blebs. CasL was needed for the normal distribution of F-actin in the cell front and phosphorylated myosin light chain in the cell rear, suggesting that CasL regulates the cytoskeletal architecture in migrating T cells. Importantly, using an in vivo allogeneic hematopoietic transplant model, we found that CasL promotes T cell migration into inflamed peripheral tissue, but was dispensable for trafficking to secondary lymphoid organs. Together, these results indicate CasL functions to control the balance of cytoskeletal components during integrin-dependent migration and highlight the importance of integrin signaling for proper migration into inflamed tissue.

Indexed as

Adaptor Proteins, Signal TransducingCell MembraneCell MovementT-LymphocytesActinsAnimalsHumansIntegrinsIntercellular Adhesion Molecule-1MiceMice, Inbred C57BLSignal TransductionActinsAdaptor Proteins, Signal TransducingIntegrinsIntercellular Adhesion Molecule-1BlebbingCasLHEF1IntegrinsMigrationNEDD9

Identifiers

PMID40576420
PMCPMC12301657

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.